Skip to content
Home/Companies/Pharma/Ojer Pharma
Ojer Pharma

Ojer Pharma

Pharma·Spain·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Ojer Pharma?

Ojer Pharma is currently owned by Easo Ventures through Easo Ventures II (2021 vintage), since 2023. Across its history, Ojer Pharma has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-08-10

Easo Ventures
Most recent investor
Easo Ventures
Easo Ventures II · 2021 · VC
2 ownership periods · full history below

Key facts

HQSpain
SectorPharma
StatusActive
Websitewww.ojerpharma.com

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Inveready Asset Management and Easo Ventures since 2014.
Co-invest · 2 holders · 2014 · present
Inveready Asset Management
Inveready Asset ManagementActive
2014 · present(12yr) · Inveready Biotech I · 2010 · Life Sciences VC
Easo Ventures
Easo VenturesActive
2023 · present(3yr) · Easo Ventures II · 2021 · VC

More from Easo Ventures II

Other portfolio companies in the same fund.

Darwin Biomedical
Active
MedTechSpain· 2026
Cloudtainer
Cloudtainer
Active
IndustrialsSpain· 2023
Soluciones Circulares de Navarra
Active
IndustrialsSpain· 2023
Tipsipos
Active
SoftwareSpain· 2023

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Ojer Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Ojer Pharma?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Ojer Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue